Eden Research (LON:EDEN) Stock Price Up 22.8% – Here’s What Happened

Eden Research plc (LON:EDEN – Get Free Report)’s stock price was up 22.8% on Monday. The company traded as high as GBX 4 and last traded at GBX 3.82. Approximately 4,710,562 shares were traded during mid-day trading, an increase of 710% from the average session volume of 581,391 shares. The stock had previously closed at GBX 3.11.

Eden Research Stock Performance

The company has a debt-to-equity ratio of 5.41, a quick ratio of 2.42 and a current ratio of 1.95. The firm has a market capitalization of £25.43 million, a P/E ratio of -7.14 and a beta of 1.55. The company has a 50-day simple moving average of GBX 2.39 and a two-hundred day simple moving average of GBX 3.04.

Eden Research (LON:EDEN – Get Free Report) last issued its quarterly earnings results on Wednesday, August 26th. The company reported GBX (0.36) earnings per share for the quarter. Eden Research had a negative net margin of 50.43% and a negative return on equity of 16.16%. As a group, equities analysts forecast that Eden Research plc will post -66.00 EPS for the current year.

About Eden Research

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.

Read More

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.